Drug Profile
Testosterone transdermal - ANI Pharmaceuticals/Antares
Alternative Names: Bio-T-Gel; LibiGel; Male testosterone gel - ANI Pharmaceuticals/Teva Pharmaceuticals USA; Testosterone ATD™ Gel; Testosterone topical gel - ANI Pharmaceuticals/Antares; Testosterone transdermal - Antares/BioSanteLatest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Antares Pharma
- Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders; Female sexual dysfunction; Hypogonadism